Step 1 topics → Reproductive → 5α-Reductase Deficiency

5α-Reductase Deficiency

USMLE Step 1 trap: Incorrectly attributes internal male duct development to DHT rather than testosterone, predicting absent Wolffian derivatives. Internal male structures (epididymis, vas deferens, seminal vesicles) develop from Wolffian ducts under testosterone, not DHT, so they are present in 5α-reductase deficiency; only DHT-dependent external genitalia are feminized.

5α-reductase deficiency is one of the highest-yield disorders of sex development on USMLE Step 1 — and the central misconception is predicting absent internal male structures when those structures are normal. In this condition, 46,XY individuals cannot convert testosterone to dihydrotestosterone (DHT). The enzyme 5α-reductase is required to produce DHT in peripheral tissues, and DHT is specifically responsible for masculinizing the external genitalia during fetal development. Because testosterone itself is intact, the internal male structures develop normally — but because DHT is absent, the external genitalia appear feminized at birth. The exam loves this condition because it forces you to distinguish which structures depend on testosterone versus DHT, and it tests whether you can reason through the hormonal logic rather than just memorize a list.

The exam hits this topic from multiple angles. The classic presentation question describes a child raised female who virilizes dramatically at puberty — the so-called 'guevedoces' (literally 'penis at 12' in the Dominican Republic, where this was first studied). Students who think DHT is required for puberty virilization get blindsided by this. The mechanism angle asks you to predict which structures are present or absent, and the labs angle asks you to interpret the testosterone-to-DHT ratio. Each of these requires applying a conceptual framework, not just pattern-matching.

The trickiest part is the internal vs. external structures distinction. Many students conflate DHT with all androgen action and predict absent Wolffian duct derivatives — that's the single most common error. USMLE Step 1 specifically exploits this by giving you a vignette with normal internal male anatomy and asking you to explain it. If your model doesn't separate testosterone (Wolffian ducts, internal structures) from DHT (external genitalia, prostate), you will miss questions that seem straightforward.

From real student decks
57%have cards covering this topic
41%have mature cards

Common misconceptions

Common mistake
Wrong: 5α-reductase deficiency causes absent internal male structures because DHT is needed for their development.
Right: Internal male structures (epididymis, vas deferens, seminal vesicles) develop from Wolffian ducts under testosterone, not DHT, so they are present in 5α-reductase deficiency; only DHT-dependent external genitalia are feminized.
Internal male duct structures — the epididymis, vas deferens, and seminal vesicles — are Wolffian duct derivatives, and their development is driven by testosterone directly, not by DHT. Since 5α-reductase deficiency leaves testosterone production and action intact, these structures form normally. DHT's job is specifically at the level of the urogenital sinus and external genitalia; confusing testosterone's role with DHT's role leads you to incorrectly predict absent male internal structures, which is the opposite of what you find on exam and in the real condition.
Common mistake
Wrong: Individuals with 5α-reductase deficiency remain phenotypically female at puberty.
Right: At puberty, the surge in testosterone (which does not require 5α-reductase) causes significant virilization including phallic enlargement, muscle development, and voice deepening — the 'guevedoces' phenomenon.
At puberty, the massive surge in testosterone does not require conversion to DHT to cause virilization — testosterone itself binds androgen receptors and drives phallic growth, muscle development, voice deepening, and other male secondary sex characteristics. The 'guevedoces' phenomenon is the clinical proof: individuals raised as girls undergo striking masculinization at puberty despite absent 5α-reductase activity. If you thought DHT was essential for pubertal virilization, this presentation becomes inexplicable; the key is that DHT is critical during fetal development but testosterone can largely compensate at puberty.
Common mistake
Gap: Misses that the diagnostic lab hallmark is an elevated testosterone-to-DHT ratio, not simply low DHT alone
5α-reductase deficiency is confirmed by an elevated testosterone:DHT ratio (>20:1), with normal-to-elevated testosterone and low DHT on labs.
The diagnostic signature of 5α-reductase deficiency is not just 'low DHT' — it's a high testosterone-to-DHT ratio, typically greater than 20:1. Testosterone is normal or even elevated (because there's no negative feedback from DHT and testosterone accumulates behind the block), while DHT is low. Looking only at low DHT misses this relationship and could confuse you with other androgen disorders. The ratio is the confirmatory test because it directly measures the enzymatic conversion step that is defective.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic clinical presentation: apparent female external genitalia at birth in a 46,XY individual, followed by dramatic virilization at puberty (phallic enlargement, voice deepening, muscle development) — the 'guevedoces' phenomenon.
  2. Explain the mechanism: internal male structures (epididymis, vas deferens, seminal vesicles) are present because they develop from Wolffian ducts under testosterone, while external genitalia are feminized because DHT is absent and required for their masculinization.
  3. Interpret the diagnostic lab pattern: elevated testosterone-to-DHT ratio (>20:1) with normal-to-elevated testosterone and low DHT, reflecting the enzymatic block at conversion.

Can you avoid these mistakes?

A 46,XY infant is born with ambiguous external genitalia and is raised female. At age 12, she develops a phallus, muscle mass, and a deepened voice. What enzyme is deficient, and what is the most likely hormonal lab finding you would expect if you measured testosterone and DHT?
In 5α-reductase deficiency, would you expect the vas deferens and epididymis to be present or absent? Explain the mechanism that determines this.
A student claims that patients with 5α-reductase deficiency remain phenotypically female for life because DHT is required for all androgen effects. What is wrong with this reasoning, and what actually happens at puberty?
How does 5α-reductase deficiency differ from complete androgen insensitivity syndrome (CAIS) in terms of internal male structures, external appearance, and hormonal labs? Sketch out the key distinctions.

Related topics

Gonadal Differentiation (SRY, MIS, Testosterone) Müllerian vs Wolffian Duct Derivatives Complete Androgen Insensitivity Syndrome (CAIS) Müllerian Anomalies (Bicornuate, Septate, MRKH)

See how your Anki deck covers this topic.

Upload your deck for a free audit →